FDA Clearance Tracker · K191266
VitalScan ANS
Last checked: Nov 20, 2026Latest source record: Jan 15, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Jan 15, 2020
Substantially Equivalent
Time to decision
250 days
Received May 10, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191266
- Device name
- VitalScan ANS
- Applicant
- Medeia, Inc.
- Applicant location
- Santa Barbara, CA
- Received
- May 10, 2019
- Decided
- Jan 15, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.2780
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JOM. The earliest in FDA's data is K760504, decided Aug 26, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191266
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medeia, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BrainView QEEG Software510(k)
K212684 · Decided Jan 28, 2023 · 522 days after receipt
Device type: Normalizing Quantitative Electroencephalograph Software (OLU) · Neurology & Neurosurgery
- NeuralScan System510(k)
K192753 · Decided Mar 17, 2020 · 169 days after receipt
Device type: Full-Montage Standard Electroencephalograph (GWQ) · Neurology & Neurosurgery
- QBioScan510(k)
K150804 · Decided Oct 19, 2015 · 207 days after receipt
Device type: Device, Galvanic Skin Response Measurement (GZO) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.